ADDF’s Fillit On FDA’s Tough Aducanumab Decision, Advances In Alzheimer’s

New Blood Test Should Aid Drug Trials, Symptomatic Treatments Advancing

 
• By Mandy Jackson
  
Alzheimer's disease on MRI
Brain imaging biomarkers are contributing to better Alzheimer's disease diagnosis and more efficient drug development • Source: Shutterstock

More from Neurological

More from Therapy Areas